Now showing items 1-2 of 2

    • Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders 

      Hervas, Amaia; Serra-Llovich, Alexandre; Rueda, Isabel; Targa, Irene; Guijarro, Silvina; Bigorra, Aitana; Cancino, Martha; Bote, Valentin; Cárcel, María; Amasi-Hartoonian, Nare; Hernández Hernández, Marta; Arranz, Maria J (Journal of Translational Genetics and Genomics, 2021, 5:278-287, 2021-07)
      Aim: About a third of patients with autism spectrum disorder (ASD) receive pharmacological treatment for comorbid symptoms. However, 30%-50% do not respond adequately and/or present severe and long-lasting ...
    • Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones 

      Duart-Castells, L.; Nadal Gratacós, Núria; Muralter, M.; Puster, B.; Berzosa Rodríguez, Xavier; Estrada Tejedor, Roger; Niello, M.; Bhat, S.; Pubill, David; Camarasa, Jordi; Sitte, H. H.; Fonseca, David; López-Arnau, Raúl (Neuropharmacology, 2021-03-15)
      The emergence of new synthetic cathinones continues to be a matter of public health concern. In fact, they are quickly replaced by new structurally related alternatives. The main goal of the present ...